Wegovy Insurance Approval. It is less popular than comparable. Your health care provider will need to submit a form to your insurance company to seek approval for wegovy ™.
Food and drug administration approved wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with. Sales were only $853 million last year because of limited insurance coverage and uptake, even as americans spent billions to lose weight. Wegovy will be approved initially for 7 months to allow for dose escalation (16 weeks) to the maintenance dosage and 12 weeks of maintenance therapy if the patient has participated in a.
